Form 4 for NRIX Nurix Therapeutics, Inc.
Accepted 2026-08-05 18:59:04 ET · period of report 2026-08-05 · accession 0001817160-26-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-05 18:59 | 2026-08-05 | NRIX | Hansen Gwenn | CSO | M - OptEx | $1.86 | +4,356 | 121.6K | +4% | +$8,102 |
| DT | 2026-08-05 18:59 | 2026-08-05 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $25.00 | -4,356 | 117.2K | -4% | -$108.9K |
| DT | 2026-08-05 18:59 | 2026-08-05 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | -4,356 | 62.3K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-05 | M | A | 4,356 | $1.86 | 121,583 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. |
| 2 | Common | Common Stock | 2026-08-05 | S | D | 4,356 | $25.00 | 117,227 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2026-08-05 | M | D | 4,356 | $0.00 | 62,310 | D | $1.86 · — to 2029-08-28 | 4,356 Common Stock | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F2) The stock option vested as to 1/48 of the total shares monthly beginning June 10, 2019 until the option was fully vested on May 10, 2023. |